Literature DB >> 12217400

An unusual inhibitory receptor--the mast cell function-associated antigen (MAFA).

Jakub Abramson1, Rong Xu, Israel Pecht.   

Abstract

The mast cell function-associated antigen (MAFA) is a type II membranal glycoprotein that was first identified on the surface of rat mucosal-type mast cells of the RBL-2H3 line. A C-type lectin domain and an immunoreceptor tyrosine-based inhibitory motif (ITIM) are located in the extracellular and intracellular domains of MAFA, respectively. Human and mouse homologues of MAFA have been discovered recently. However, they are expressed also or only by NK and T-cells, where they most probably play different roles. MAFA clustering by its specific antibody mAb G63 has been previously shown to cause a dose-dependent inhibition of the secretory response of these cells to the FcepsilonRI stimulus. More recent results established that MAFA's inhibitory action involves at least two different enzymes: Following the tyrosyl-phosphorylation of MAFA ITIM by the PTK Lyn, two phosphatases SHIP and SHP2 are recruited to it at the plasma membrane where they propagate the inhibitory signals. The following is a brief report on this unusual inhibitory receptor and its functional activities.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12217400     DOI: 10.1016/s0161-5890(02)00080-9

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  10 in total

Review 1.  KLRG1--more than a marker for T cell senescence.

Authors:  Sian M Henson; Arne N Akbar
Journal:  Age (Dordr)       Date:  2009-12

Review 2.  Inhibitor and activator: dual functions for SHIP in immunity and cancer.

Authors:  William G Kerr
Journal:  Ann N Y Acad Sci       Date:  2010-12-13       Impact factor: 5.691

3.  Selective inhibition of the Fc epsilon RI-induced de novo synthesis of mediators by an inhibitory receptor.

Authors:  Jakub Abramson; Arieh Licht; Israel Pecht
Journal:  EMBO J       Date:  2006-01-12       Impact factor: 11.598

Review 4.  New Targets for Antiviral Therapy: Inhibitory Receptors and Immune Checkpoints on Myeloid Cells.

Authors:  Yanni Liu; Paul Nicklin; Yuan He
Journal:  Viruses       Date:  2022-05-25       Impact factor: 5.818

Review 5.  The Yin and Yang of Targeting KLRG1+ Tregs and Effector Cells.

Authors:  Samantha M Borys; Arup K Bag; Laurent Brossay; Dennis O Adeegbe
Journal:  Front Immunol       Date:  2022-04-29       Impact factor: 8.786

6.  KLRG1 negatively regulates natural killer cell functions through the Akt pathway in individuals with chronic hepatitis C virus infection.

Authors:  Jia M Wang; Yong Q Cheng; Lei Shi; Ruo S Ying; Xiao Y Wu; Guang Y Li; Jonathan P Moorman; Zhi Q Yao
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

Review 7.  Immunoglobulin E receptor signaling and asthma.

Authors:  Lawren C Wu
Journal:  J Biol Chem       Date:  2011-07-28       Impact factor: 5.157

Review 8.  Mast cell function: a new vision of an old cell.

Authors:  Elaine Zayas Marcelino da Silva; Maria Célia Jamur; Constance Oliver
Journal:  J Histochem Cytochem       Date:  2014-07-25       Impact factor: 2.479

Review 9.  Strategies for Mast Cell Inhibition in Food Allergy.

Authors:  Jada Suber; Onyinye I Iweala
Journal:  Yale J Biol Med       Date:  2020-12-29

10.  Killer cell lectin-like receptor G1 binds three members of the classical cadherin family to inhibit NK cell cytotoxicity.

Authors:  Masayuki Ito; Takuma Maruyama; Naotoshi Saito; Satoru Koganei; Kazuo Yamamoto; Naoki Matsumoto
Journal:  J Exp Med       Date:  2006-02-06       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.